Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Colorectal Neoplasms

  Free Subscription


Articles published in Cancer Lett

Retrieve available abstracts of 73 articles:
HTML format



Single Articles


    March 2024
  1. TANG Y, Wei J, Ge X, Yu C, et al
    Intratumoral injection of interferon gamma promotes the efficacy anti-PD1 treatment in colorectal cancer.
    Cancer Lett. 2024 Mar 9:216798. doi: 10.1016/j.canlet.2024.216798.
    PubMed     Abstract available


  2. CHEN Q, Deng Y, Li Y, Chen J, et al
    Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
    Cancer Lett. 2024 Mar 6:216778. doi: 10.1016/j.canlet.2024.216778.
    PubMed     Abstract available


    February 2024
  3. TAN R, Zhang Z, Ding P, Liu Y, et al
    A growth factor-reduced culture system for colorectal cancer organoids.
    Cancer Lett. 2024 Feb 19:216737. doi: 10.1016/j.canlet.2024.216737.
    PubMed     Abstract available


  4. POTHURAJU R, Khan I, Jain M, Bouvet M, et al
    Colorectal cancer murine models: Initiation to metastasis.
    Cancer Lett. 2024 Feb 13:216704. doi: 10.1016/j.canlet.2024.216704.
    PubMed     Abstract available


  5. XU B, Jia Q, Liao X, Fan T, et al
    Inositol hexaphosphate enhances chemotherapy by reversing senescence induced by persistently activated PERK and diphthamide modification of eEF2.
    Cancer Lett. 2024;582:216591.
    PubMed     Abstract available


    January 2024
  6. ZHU J, Li J, Yang K, Chen Y, et al
    NR4A1 depletion inhibits colorectal cancer progression by promoting necroptosis via the RIG-I-like receptor pathway.
    Cancer Lett. 2024 Jan 30:216693. doi: 10.1016/j.canlet.2024.216693.
    PubMed     Abstract available


  7. TANG J, Lam GT, Brooks RD, Miles M, et al
    Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
    Cancer Lett. 2024 Jan 28:216639. doi: 10.1016/j.canlet.2024.216639.
    PubMed     Abstract available


  8. WEN X, Qin J, Zhang X, Ye L, et al
    MEK-mediated CHPF2 phosphorylation promotes colorectal cancer cell proliferation and metastasis by activating NF-kappaB signaling.
    Cancer Lett. 2024 Jan 21:216644. doi: 10.1016/j.canlet.2024.216644.
    PubMed     Abstract available


  9. JI L, Fu G, Huang M, Kao X, et al
    scRNA-seq of colorectal cancer shows regional immune atlas with the function of CD20(+) B cells.
    Cancer Lett. 2024 Jan 20:216664. doi: 10.1016/j.canlet.2024.216664.
    PubMed     Abstract available


  10. LIU C, Cheng X, Han K, Hong L, et al
    A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Cancer Lett. 2024 Jan 19:216663. doi: 10.1016/j.canlet.2024.216663.
    PubMed     Abstract available


  11. MORINO S, Mashima T, Shirai F, Nagayama S, et al
    BET protein-dependent E2F pathway activity confers bell-shaped type resistance to tankyrase inhibitors in APC-mutated colorectal cancer.
    Cancer Lett. 2024 Jan 10:216632. doi: 10.1016/j.canlet.2024.216632.
    PubMed     Abstract available


    December 2023
  12. JIANG X, Yang L, Chen G, Feng X, et al
    Discovery of Kinetin in inhibiting colorectal cancer progression via enhancing PSMB1-mediated RAB34 degradation.
    Cancer Lett. 2023 Dec 28:216600. doi: 10.1016/j.canlet.2023.216600.
    PubMed     Abstract available


  13. DAI X, Chen W, Qiao Y, Chen X, et al
    Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3beta/TCF7/MMP9 pathway and synergies with capecitabine.
    Cancer Lett. 2023 Dec 13:216596. doi: 10.1016/j.canlet.2023.216596.
    PubMed     Abstract available


    November 2023
  14. MA J, Liu Y, Yuan J, Ma Y, et al
    Bcl-xL mediates interferon-beta secretion by protease-activated receptor 2 deficiency through the mitochondrial permeability transition pore in colorectal cancer metastasis.
    Cancer Lett. 2023 Nov 14:216483. doi: 10.1016/j.canlet.2023.216483.
    PubMed     Abstract available


  15. PRIMEAUX M, Liu X, Gowrikumar S, Fatima I, et al
    Claudin-1 interacts with EPHA2 to promote cancer stemness and chemoresistance in colorectal cancer.
    Cancer Lett. 2023;579:216479.
    PubMed     Abstract available


    October 2023
  16. HONG WF, Zhu DX, Chen YJ, Shen XZ, et al
    Coiled-coil domain-containing 154 promotes colorectal cancer proliferation and metastasis via interacting with Minichromosome maintenance complex component 2.
    Cancer Lett. 2023 Oct 18:216460. doi: 10.1016/j.canlet.2023.216460.
    PubMed     Abstract available


  17. YANG J, Liao Y, Wang B, Cui L, et al
    EDARADD promotes colon cancer progression by suppressing E3 ligase Trim21-mediated ubiquitination and degradation of Snail.
    Cancer Lett. 2023;577:216427.
    PubMed     Abstract available


  18. GOU H, Wong CC, Chen H, Shang H, et al
    TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
    Cancer Lett. 2023 Oct 10:216438. doi: 10.1016/j.canlet.2023.216438.
    PubMed     Abstract available


  19. ZHOU X, Fu D, Yang H, Le C, et al
    Rigosertib promotes anti-tumor immunity via autophagic degradation of PD-L1 in colorectal cancer cells.
    Cancer Lett. 2023 Oct 5:216422. doi: 10.1016/j.canlet.2023.216422.
    PubMed     Abstract available


    September 2023
  20. CHEN L, Sun K, Qin W, Huang B, et al
    LIMK1 m(6)A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation.
    Cancer Lett. 2023 Sep 29:216420. doi: 10.1016/j.canlet.2023.216420.
    PubMed     Abstract available


  21. MORRIS MT, Jain A, Sun B, Kurbatov V, et al
    Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis.
    Cancer Lett. 2023 Sep 14:216384. doi: 10.1016/j.canlet.2023.216384.
    PubMed     Abstract available


    August 2023
  22. ZHUO FF, Li L, Liu TT, Liang XM, et al
    Lycorine promotes IDH1 acetylation to induce mitochondrial dynamics imbalance in colorectal cancer cells.
    Cancer Lett. 2023 Aug 28:216364. doi: 10.1016/j.canlet.2023.216364.
    PubMed     Abstract available


    July 2023
  23. PAN G, Zhang K, Geng S, Lan C, et al
    Corrigendum to "PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer" [Cancer Lett. 531 (2022) 109-123].
    Cancer Lett. 2023 Jul 10:216290. doi: 10.1016/j.canlet.2023.216290.
    PubMed    


  24. TER STEEGE EJ, Doornbos LW, Haughton PD, van Diest PJ, et al
    R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling.
    Cancer Lett. 2023 Jul 3:216301. doi: 10.1016/j.canlet.2023.216301.
    PubMed     Abstract available


    June 2023
  25. YAN W, Qiu L, Yang M, Xu A, et al
    CXCL10 mediates CD8(+) T cells to facilitate vessel normalization and improve the efficacy of cetuximab combined with PD-1 checkpoint inhibitors in colorectal cancer.
    Cancer Lett. 2023;567:216263.
    PubMed     Abstract available


  26. HONDO N, Kitazawa M, Koyama M, Nakamura S, et al
    MEK inhibitor and anti-EGFR antibody overcome sotorasib resistance signals and enhance its antitumor effect in colorectal cancer cells.
    Cancer Lett. 2023;567:216264.
    PubMed     Abstract available


  27. RIGILLO G, Belluti S, Campani V, Ragazzini G, et al
    The NF-Y splicing signature controls hybrid EMT and ECM-related pathways to promote aggressiveness of colon cancer.
    Cancer Lett. 2023 Jun 10:216262. doi: 10.1016/j.canlet.2023.216262.
    PubMed     Abstract available


    May 2023
  28. XU K, Yin X, Zhou B, Zheng X, et al
    FOSL2 promotes intertumoral infiltration of T cells and increases pathological complete response rates in locally advanced rectal cancer patients.
    Cancer Lett. 2023;562:216145.
    PubMed     Abstract available


  29. LONG Y, Wang Y, Qu M, Zhang D, et al
    Combined inhibition of EZH2 and the autotaxin-LPA-LPA2 axis exerts synergistic antitumor effects on colon cancer cells.
    Cancer Lett. 2023 May 23:216226. doi: 10.1016/j.canlet.2023.216226.
    PubMed     Abstract available


  30. SHARMA A, Kumar R, Yadav G, Garg P, et al
    Artificial intelligence in intestinal polyp and colorectal cancer prediction.
    Cancer Lett. 2023;565:216238.
    PubMed     Abstract available


  31. HONG JH, Woo IS
    Metronomic chemotherapy as a potential partner of immune checkpoint inhibitors for metastatic colorectal cancer treatment.
    Cancer Lett. 2023;565:216236.
    PubMed     Abstract available


    March 2023
  32. CONI S, Bordone R, Ivy DM, Yurtsever ZN, et al
    Combined inhibition of polyamine metabolism and eIF5A hypusination suppresses colorectal cancer growth through a converging effect on MYC translation.
    Cancer Lett. 2023 Mar 7:216120. doi: 10.1016/j.canlet.2023.216120.
    PubMed     Abstract available


  33. MORIMOTO Y, Yamashita N, Hirose H, Fushimi A, et al
    MUC1-C is necessary for SHP2 activation and BRAF inhibitor resistance in BRAF(V600E) mutant colorectal cancer.
    Cancer Lett. 2023;559:216116.
    PubMed     Abstract available


    February 2023
  34. ONCLERCQ-DELIC R, Buhagiar-Labarchede G, Leboucher S, Larcher T, et al
    Cytidine deaminase deficiency in mice enhances genetic instability but limits the number of chemically induced colon tumors.
    Cancer Lett. 2023;555:216030.
    PubMed     Abstract available


  35. TAN X, Zhang Z, Yao H, Shen L, et al
    Retraction notice to "Tim-4 promotes the growth of colorectal cancer by activating angiogenesis and recruiting tumor-associated macrophages via the PI3K/AKT/mTOR signaling pathway" [Canc. Lett. 436 (2018) 119-128].
    Cancer Lett. 2023 Feb 21:216060. doi: 10.1016/j.canlet.2023.216060.
    PubMed     Abstract available


    December 2022
  36. ZHENG Z, Hou X, Bian Z, Jia W, et al
    Gut microbiota and colorectal cancer metastasis.
    Cancer Lett. 2022;555:216039.
    PubMed     Abstract available


    November 2022
  37. WANG SY, Zhang LJ, Chen GJ, Ni QQ, et al
    COPA A-to-I RNA editing hijacks endoplasmic reticulum stress to promote metastasis in colorectal cancer.
    Cancer Lett. 2022;553:215995.
    PubMed     Abstract available


    September 2022
  38. DENG Y, Gao J, Xu G, Yao Y, et al
    HDAC6-dependent deacetylation of AKAP12 dictates its ubiquitination and promotes colon cancer metastasis.
    Cancer Lett. 2022 Sep 16:215911. doi: 10.1016/j.canlet.2022.215911.
    PubMed     Abstract available


  39. SHEN D, Luo J, Chen L, Ma W, et al
    PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer.
    Cancer Lett. 2022 Sep 15:215919. doi: 10.1016/j.canlet.2022.215919.
    PubMed     Abstract available


  40. TSAI HY, Bronner MP, March JK, Valentine JF, et al
    Metabolic targeting of NRF2 potentiates the efficacy of the TRAP1 inhibitor G-TPP through reduction of ROS detoxification in colorectal cancer.
    Cancer Lett. 2022 Sep 13:215915. doi: 10.1016/j.canlet.2022.215915.
    PubMed     Abstract available


  41. SHIMIZU Y, Maruyama K, Suzuki M, Kawachi H, et al
    Acquired resistance to BRAF inhibitors is mediated by BRAF splicing variants in BRAF V600E mutation-positive colorectal neuroendocrine carcinoma.
    Cancer Lett. 2022;543:215799.
    PubMed     Abstract available


  42. CHEN TW, Hung WZ, Chiang SF, Chen WT, et al
    Dual inhibition of TGFbeta signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1.
    Cancer Lett. 2022;543:215795.
    PubMed     Abstract available


  43. SONG CH, Kim N, Nam RH, Choi SI, et al
    Combination treatment with 17beta-estradiol and anti-PD-L1 suppresses MC38 tumor growth by reducing PD-L1 expression and enhancing M1 macrophage population in MC38 colon tumor model.
    Cancer Lett. 2022;543:215780.
    PubMed     Abstract available


    August 2022
  44. WALTERSKIRCHEN N, Muller C, Ramos C, Zeindl S, et al
    Metastatic colorectal carcinoma-associated fibroblasts have immunosuppressive properties related to increased IGFBP2 expression.
    Cancer Lett. 2022;540:215737.
    PubMed     Abstract available


    July 2022
  45. ZHAO W, Jin L, Chen P, Li D, et al
    Colorectal cancer immunotherapy-Recent progress and future directions.
    Cancer Lett. 2022 Jul 7:215816. doi: 10.1016/j.canlet.2022.215816.
    PubMed     Abstract available


    June 2022
  46. ALVES JM, Prado-Lopez S, Tomas L, Valecha M, et al
    Clonality and timing of relapsing colorectal cancer metastasis revealed through whole-genome single-cell sequencing.
    Cancer Lett. 2022;543:215767.
    PubMed     Abstract available


    May 2022
  47. CHENG Q, Zheng H, Li M, Wang H, et al
    LGR4 cooperates with PrPc to endow the stemness of colorectal cancer stem cells contributing to tumorigenesis and liver metastasis.
    Cancer Lett. 2022;540:215725.
    PubMed     Abstract available


  48. WANG Q, Jiang D, Ye Q, Zhou W, et al
    A widely expressed free immunoglobulin kappa chain with a unique Vkappa4-1/Jkappa3 pattern promotes colon cancer invasion and metastasis by activating the integrin beta1/FAK pathway.
    Cancer Lett. 2022 May 6:215720. doi: 10.1016/j.canlet.2022.215720.
    PubMed     Abstract available


    April 2022
  49. YAMADA H, Takeshima H, Fujiki R, Yamashita S, et al
    ARID1A loss-of-function induces CpG island methylator phenotype.
    Cancer Lett. 2022;532:215587.
    PubMed     Abstract available


    March 2022
  50. TANG K, Wu Z, Sun M, Huang X, et al
    Elevated MMP10/13 mediated barrier disruption and NF-kappaB activation aggravate colitis and colon tumorigenesis in both individual or full miR-148/152 family knockout mice.
    Cancer Lett. 2022;529:53-69.
    PubMed     Abstract available


  51. DUAN JJ, Wang D, Cai J, Chen JJ, et al
    An aldehyde dehydrogenase 1A3 inhibitor attenuates the metastasis of human colorectal cancer.
    Cancer Lett. 2022 Mar 21:215662. doi: 10.1016/j.canlet.2022.215662.
    PubMed     Abstract available


  52. SHEN Z, Li Z, Liu Y, Li Y, et al
    GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer.
    Cancer Lett. 2022;534:215617.
    PubMed     Abstract available


    February 2022
  53. JIANG X, Wang C, Ke Z, Duo L, et al
    The ion channel TRPV1 gain-of-function reprograms the immune microenvironment to facilitate colorectal tumorigenesis.
    Cancer Lett. 2022;527:95-106.
    PubMed     Abstract available


  54. DINAMI R, Petti E, Porru M, Rizzo A, et al
    TRF2 cooperates with CTCF for controlling the oncomiR-193b-3p in colorectal cancer.
    Cancer Lett. 2022 Feb 28:215607. doi: 10.1016/j.canlet.2022.215607.
    PubMed     Abstract available


  55. YANG J, Guo W, Lu M
    Letter to the editor regarding"Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E''.
    Cancer Lett. 2022 Feb 11. pii: S0304-3835(22)00038.
    PubMed    


  56. FENG S, Huang Q, Deng J, Jia W, et al
    DAB2IP suppresses tumor malignancy by inhibiting GRP75-driven p53 ubiquitination in colon cancer.
    Cancer Lett. 2022;532:215588.
    PubMed     Abstract available


  57. AN Y, Xu B, Yan G, Wang N, et al
    YAP derived circ-LECRC functions as a "brake signal" to suppress hyperactivation of oncogenic YAP signalling in colorectal cancer.
    Cancer Lett. 2022 Feb 4:215589. doi: 10.1016/j.canlet.2022.215589.
    PubMed     Abstract available


  58. KE CH, Wang YS, Chiang HC, Wu HY, et al
    Xenograft cancer vaccines prepared from immunodeficient mice increase tumor antigen diversity and host T cell efficiency against colorectal cancers.
    Cancer Lett. 2022;526:66-75.
    PubMed     Abstract available


    January 2022
  59. GONG K, Hong Q, Wu H, Wang F, et al
    Gap junctions mediate glucose transfer to promote colon cancer growth in three-dimensional spheroid culture.
    Cancer Lett. 2022 Jan 27. pii: S0304-3835(22)00039.
    PubMed     Abstract available


  60. PAN G, Zhang K, Geng S, Lan C, et al
    PHF14 knockdown causes apoptosis by inducing DNA damage and impairing the activity of the damage response complex in colorectal cancer.
    Cancer Lett. 2022 Jan 21. pii: S0304-3835(22)00002.
    PubMed     Abstract available


  61. WANG H, Shao Q, Wang J, Zhao L, et al
    Decreased CXCR2 expression on circulating monocytes of colorectal cancer impairs recruitment and induces Re-education of tumor-associated macrophages.
    Cancer Lett. 2022;529:112-125.
    PubMed     Abstract available


  62. HUANG M, Liu M, Huang D, Ma Y, et al
    Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway.
    Cancer Lett. 2022;524:131-143.
    PubMed     Abstract available


    December 2021
  63. TAN G, Lin C, Huang C, Chen B, et al
    Radiosensitivity of colorectal cancer and radiation-induced gut damages are regulated by gasdermin E.
    Cancer Lett. 2021;529:1-10.
    PubMed     Abstract available


  64. SHAO X, Sun S, Zhou Y, Wang H, et al
    Bacteroides fragilis restricts colitis-associated cancer via negative regulation of the NLRP3 axis.
    Cancer Lett. 2021;523:170-181.
    PubMed     Abstract available


  65. ZHONG F, Lin Y, Jing X, Ye Y, et al
    Innate tumor killers in colorectal cancer.
    Cancer Lett. 2021;527:115-126.
    PubMed     Abstract available


  66. MA R, Liu Y, Che X, Li C, et al
    Nuclear PD-L1 promotes cell cycle progression of BRAF-mutated colorectal cancer by inhibiting THRAP3.
    Cancer Lett. 2021 Dec 16. pii: S0304-3835(21)00630.
    PubMed     Abstract available


    November 2021
  67. HOU H, Chen D, Zhang K, Zhang W, et al
    Gut microbiota-derived short-chain fatty acids and colorectal cancer: Ready for clinical translation?
    Cancer Lett. 2021 Nov 26. pii: S0304-3835(21)00600.
    PubMed     Abstract available


  68. WANG D, Wang X, Si M, Yang J, et al
    Corrigendum to "Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages" [Canc. Lett. 474 (2020) 36-52].
    Cancer Lett. 2021 Nov 13. pii: S0304-3835(21)00577.
    PubMed    


  69. SCHURMANN L, Schumacher L, Roquette K, Brozovic A, et al
    Inhibition of the DSB repair protein RAD51 potentiates the cytotoxic efficacy of doxorubicin via promoting apoptosis-related death pathways.
    Cancer Lett. 2021;520:361-373.
    PubMed     Abstract available


  70. PIN F, Prideaux M, Huot JR, Essex AL, et al
    Non-bone metastatic cancers promote osteocyte-induced bone destruction.
    Cancer Lett. 2021;520:80-90.
    PubMed     Abstract available


    September 2021
  71. LI N, Lu B, Luo C, Cai J, et al
    Incidence, mortality, survival, risk factor and screening of colorectal cancer: A comparison among China, Europe, and northern America.
    Cancer Lett. 2021;522:255-268.
    PubMed     Abstract available


  72. YIN Y, Jiang Z, Fu J, Li Y, et al
    Choline-induced SLC5A7 impairs colorectal cancer growth by stabilizing p53 protein.
    Cancer Lett. 2021 Sep 22. pii: S0304-3835(21)00481.
    PubMed     Abstract available


  73. BAI D, Sun T, Zhao J, Du J, et al
    Oroxylin A maintains the colonic mucus barrier to reduce disease susceptibility by reconstituting a dietary fiber-deprived gut microbiota.
    Cancer Lett. 2021;515:73-85.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.